Monsanto Company (MON) : Cranbrook Wealth Management reduced its stake in Monsanto Company by 33.33% during the most recent quarter end. The investment management company now holds a total of 28 shares of Monsanto Company which is valued at $2,922 after selling 14 shares in Monsanto Company , the firm said in a disclosure report filed with the SEC on Aug 2, 2016.
Other Hedge Funds, Including , Investors Capital Advisory Services reduced its stake in MON by selling 990 shares or 5.5% in the most recent quarter. The Hedge Fund company now holds 17,015 shares of MON which is valued at $1,775,685. Monsanto Company makes up approx 0.34% of Investors Capital Advisory Services’s portfolio.Pillar Pacific Capital Management boosted its stake in MON in the latest quarter, The investment management firm added 1,399 additional shares and now holds a total of 53,899 shares of Monsanto Company which is valued at $5,624,900. Monsanto Company makes up approx 0.91% of Pillar Pacific Capital Management’s portfolio. Artemis Investment Management Llp added MON to its portfolio by purchasing 119,363 company shares during the most recent quarter which is valued at $12,742,000. Monsanto Company makes up approx 0.33% of Artemis Investment Management Llp’s portfolio.Louisiana State Employees Retirement System reduced its stake in MON by selling 800 shares or 2.71% in the most recent quarter. The Hedge Fund company now holds 28,700 shares of MON which is valued at $3,063,725. Monsanto Company makes up approx 0.16% of Louisiana State Employees Retirement System’s portfolio. Eqis Capital Management sold out all of its stake in MON during the most recent quarter. The investment firm sold 2,688 shares of MON which is valued $286,111.
Monsanto Company closed down -0.18 points or -0.17% at $106.75 with 13,66,678 shares getting traded on Monday. Post opening the session at $107.5, the shares hit an intraday low of $106.41 and an intraday high of $107.655 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, Monsanto Company reported $2.17 EPS for the quarter, missing the analyst consensus estimate by $ -0.23 based on the information available during the earnings call on Jun 29, 2016. Analyst had a consensus of $2.40. The company had revenue of $4189.00 million for the quarter, compared to analysts expectations of $4487.57 million. The company’s revenue was down -8.5 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.39 EPS.
Many Wall Street Analysts have commented on Monsanto Company. Monness Crespi & Hardt Upgraded Monsanto Company on Aug 8, 2016 to ” Buy”, Price Target of the shares are set at $130.Monsanto Company was Upgraded by Jefferies to ” Buy” on May 25, 2016.
Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.